Janux Therapeutics JANX Capital investments accrued but not yet paid
Capital investments accrued but not yet paid at other companies
Other financials
Where this comes from
Reported directly by Janux Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CapitalExpendituresIncurredButNotYetPaid.
The official record: Janux Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Janux Therapeutics's capital investments accrued but not yet paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Janux Therapeutics's capital investments accrued but not yet paid?
- Janux Therapeutics (JANX) reported capital investments accrued but not yet paid of $25K in Q1 2026.
- How has Janux Therapeutics's capital investments accrued but not yet paid changed year-over-year?
- Janux Therapeutics's capital investments accrued but not yet paid decreased by 89.5% year-over-year, from $237K to $25K.